VALPERPRO-CFTRNCT07889973
A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Molecular and Functional Characterization
Timeframe: through study completion, an average of 2 years
Arms and interventions
Patients with cystic fibrosis
Patients with cystic fibrosis
children with CFSPID
children with CFSPID
patients with idiopathic bronchiectasis
patients with idiopathic bronchiectasis
Patients with CFTR-related disorder
Patients with CFTR-related disorder
Sites
3 sites in 1 country